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ABSTRACT Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex
interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription
factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we con-
struct amathematicalmodel of the IP3 signal production systemafter stimulation by a hypertrophica-adrenergic agonist (endothelin-1)
in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the
resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to pre-
coupled (with GaGDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated
with the receptor systemcontribute to thebehavior of the system toagreat extent,with precoupled receptors driving the response to
extracellular ligand. Finally, by reparameterizing for a second hypertrophic a-adrenergic agonist, angiotensin-II, we show that
differences in key receptor kinetic and membrane density parameters are sufﬁcient to explain different observed IP3 transients in
essentially the same pathway.
INTRODUCTION
Pathological cardiac hypertrophy has been identiﬁed as a
major risk factor leading to heart failure (1). An understanding
of the biological pathways involved in cardiac hypertrophy
may yield beneﬁts in understanding the progression of, and
the development of therapies for, cardiac disease.
A range of signal transduction pathways are implicated in
hypertrophy, including the inositol 1,4,5-trisphosphate (IP3)-
calcineurin pathway, the mitogen-activated protein kinase p42/
p44, mitogen-activated protein kinase p38, jun N-terminal
kinase, and the phosphoinositide 3-kinase-wingless-related
mouse mammary tumor virus integration (PI3K-Wnt) path-
ways (2–10). In vivo, none has a monopoly on hypertrophic
effects and many pathways interact (3), the details of which
have yet to be fully elucidated experimentally.
The role of the IP3-calcineurin pathway in cardiac hyper-
trophy was discovered during the 1990s and, despite some
initial controversy, calcineurin’s role has now been accepted.
Extracellular agonists stimulate Gq-family G-protein-coupled
receptors (GPCRs). On stimulation, the G-protein a-subunit
activates phospholipase C (PLC) (11,12), and causes hydroly-
sis of membrane-bound phosphatidyl inositol-4,5-bisphosphate
(PIP2). This forms the secondary messenger IP3. IP3 pro-
duction causes an increase in the intracellular calcium con-
centration ([Ca21]i), which in turn activates the phosphatase
calcineurin. Calcineurin activation leads to changes in gene
expression by facilitating translocation to the nucleus of cy-
tosolic transcription factors of the nuclear factor of activated
T cells (NFAT) family. There such factors bind to nuclear
DNA cooperatively with transcription factors from the other
hypertrophic pathways to facilitate transcription (13). NFAT’s
ability to act as a signal integrator for hypertrophy (14) in this
manner is a key reason that the IP3-calcineurin pathway is sig-
niﬁcant.
These ﬁndings have motivated the use of existing im-
munosuppressive calcineurin inhibitors (such as Cyclosporin
A and FK506) as experimental attenuators of hypertrophy. The
results of that approach have been conﬂicting, with similar
rodent models exhibiting no effect, attenuation, or even com-
plete prevention of hypertrophy, and occasionally lethal
side-effects from the immunosuppressors (15). Thus, a more
detailed understanding of the pathways for hypertrophy is
necessary for the development of practical therapeutic treat-
ments.
The biological processes of the IP3 production system
represent only a tiny proportion of the activities within a cell,
yet even these are complex with many players and diverse
interactions. For such systems a computational model is a
useful tool (16), bringing together quantitative and qualita-
tive data to allow interactive exploration of our understand-
ing. Currently no mathematical model for the IP3-calcineurin
pathway exists in the cardiac myocyte.
This work focuses on modeling the signal transduction
pathway from extracellular agonist to the production of IP3
by the extracellular agonists endothelin-1 (17) (ET-1) and
angiotensin-II (18) (Ang-2). The responses of IP3 to the two
agonists are different, despite the signal transduction path-
way being almost identical. We construct the ﬁrst mathe-
matical model of the IP3 production and degradation signal
transduction system in the mouse atrial cardiac myocyte, as
stimulated by the hypertrophic agonist ET-1. Sensitivity
analysis was undertaken to determine which parameters are
signiﬁcant in determining features of the IP3 transient. We
investigate possible causes of the different IP3 response from
stimulation with Ang-2, and show that the differences in
system behavior are explainable in terms of receptor kinetics.
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METHODS
We constructed a mathematical model of the IP3 production system as
stimulated by the a-adrenergic agonist ET-1 in the atrial cardiac myocyte.
Since experimental processes are often time consuming and costly, it is im-
portant to assess from current knowledge what the most inﬂuential param-
eters are that determine properties of the system.We applied a global sensitivity
analysis (the Morris Method) to determine the important parameters of the
system by their inﬂuence on ﬁve characteristics of stimulated IP3 transients.
Using the ET-1 model as a baseline, we then reﬁned the model to stim-
ulation with the alternative agonist Ang-2. Ang-2 is a hormone produced via
the angiotensin-renin system, and also produced locally on stretch of the
cardiomyocyte (18,19). Ang-2 signals are received by two main isoforms of
the Ang-2 receptor-Type 1 (AT-1) and Type 2 (AT-2). Cells from different
animals contain different proportions of each although the proportion is
approximately equal in rodents such as the rat (20). There is evidence linking
AT-1 receptors to PLCb, IP3 production, and calcium release via Gq family
GPCRs (21–23). Transients resulting from stimulation with Ang-2 are much
shorter-lived than those from ET-1, despite the fact that the same pathway is
activated in both cases. We sought to determine whether the different tran-
sient behavior between the two agonists can be explained in our model by
altering key parameters of the receptor alone. We found that the necessary
changes to the model could be both motivated and understood by con-
sidering the results of the previously completed sensitivity analysis.
Model construction
We developed a mathematical model of the signiﬁcant biological processes
relating to the transduction of extracellular ligand signals through Gq family
receptors and subsequent IP3 production in the mouse atrial cardiac myocyte.
A reaction scheme of the model is shown in Fig. 1. The model encompasses
the extracellular ligand (L), the GPCRs (R), activation of phospholipase Cb
(P) by GaGTP (Gt) subunits, and both the basal and stimulated hydrolysis
of PIP2 to form IP3. Conceptually, the model can be divided into three
modules:
1. GPCR cycling, dealing with ligand, receptors, and diffusible Ga mes-
sengers.
2. PLCb cycling, dealing with the activation of PLCb.
3. IP3 production and degradation, concerned with the hydrolysis of IP3
from PIP2, and the background consumption of IP3.
The mathematical model was formulated using mass action kinetics, and
implemented as a system of ordinary differential equations. For conve-
nience, the model was encoded into the computer-readable protocol Cellular
modeling Markup Language (CellML) (24). A complete list of the model
equations, and a list of model parameters and initial conditions are provided
in Tables 3 and 4, respectively. This signal transduction pathway involves
interactions between membrane-bound and freely diffusing cytosolic
species. Cytosolic species are represented by concentration (in mM) while
FIGURE 1 Reaction scheme of the IP3 production system. The extracellular ligand (L) binds to receptors (R), whether precoupled with GaGDP (Gd, yielding
Rlg) or not (Rl). Fully activated receptors (Rlg) release GaGTP (Gt), which, along with calcium (Ca), stimulates PLCb (P). In the unstimulated state, PLCb-
Ca21 (Pc) hydrolyzes PIP2 to produce IP3 via reaction R14. When stimulated, PLCb-Ca
21-GaGTP (Pcg) hydrolyses PIP2 at a faster rate via reaction R15. Free
IP3 is degraded via reaction R16.
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membrane-bound species are given as area densities (number per unit of
membrane area, inmm2). The model is also available as CellML code in the
online CellML Repository (http://www.cellml.org/models).
GPCR cycling
Extracellular ligand (L) binds to cell-surface receptors (R), shown by re-
versible reactions R1 and R4 in Fig. 1. For Gq family receptors, this binding
causes a conformational change which replaces GDP with a GTP on an at-
tached G-protein’s a-subunit. This causes the Ga subunit to dissociate (re-
action R6) and stimulate other proteins inside the cell. For a receptor
to transduce the ligand signal across the membrane, it requires both an at-
tached G-protein and a ligand-binding event. The model utilizes the receptor
components from a nonexcitable cell model of Lukas (25) that uses the
precoupled-receptor concept (26): should the Ga subunit bind ﬁrst (as shown
in reaction R2), then the receptor is known as precoupled (Rg), and exhibits a
higher afﬁnity for the ligand than if Ga had bound after the ligand (via
reaction R3). Only the state where both ligand and Ga subunit are bound is
considered an activated receptor (Rlg). Active receptors are targeted for
phosphorylation and eventual invagination and recycling by the cellular
machinery. Once phosphorylated, the receptor is no longer available for
further signal transduction. For the purposes of the model, this is abstracted
into a one-time phosphorylation step (reaction R5).
The model is designed to simulate experiments where the cell is initially
unstimulated. At a predetermined stimulation timepoint (ts), ligand is added,
which is represented by a (smoothed) Heaviside step function to the desired
stimulation concentration (Ls). The amount of ligand bound to receptors is
assumed negligible compared to the total amount of ligand available, hence
the concentration of free ligand in the model does not decrease as ligand
binds to the receptors.
All reactions were modeled as kinetic ﬂuxes following the Law of Mass





is given by the ﬂux expression
J1 ¼ kf; 13R3 L kr; 13Rl;
where R is the receptor area density in mm2, L is the extracellular ligand
concentration in mM, Rl is the density of receptors with ligand bound in
mm2, and kf,1 and kr,1 are rate constants measured in mM
1 s1 and s1,
respectively. J1 is therefore a ﬂux measured in mm
2 s1.
Endothelins bind to their receptors with high enough afﬁnity for the
reaction to be considered irreversible under physiological conditions (27),
hence it seems likely that when the active Ga subunit dissociates during re-
action R6, the ligand and receptor complex (Rl) remains together.
PLCb cycling
The active GaGTP messenger (Gt) released from stimulated receptors binds
to the enzyme PLCb (P), shown in Fig. 1 as the reversible reactions R9 and
R10. This binding can be considered independently from the binding of the
costimulatory calcium ions (Ca) shown in reversible reactions R8 and R11.
Free GaGTP degrades to GaGDP via a self-GTPase activity of the a-subunit,
removing its ability to stimulate PLCb, represented as reaction R7. This
activity in PLCb-bound GaGTP and dissociation from PLCb is assumed for
modeling purposes to occur in the same step and is shown by reactions R12
and R13 depending on whether Ca21 is also bound or not. When bound to
PLCb, this step is assumed to occur at the same rate, irrespective of the
additional presence or absence of bound calcium (from Pcg or Pg, respec-
tively).
The formulation of the reactions R7-R13 follows the same form described
in GPCR cycling above, although for some reactions an additional conver-
sion factor is required: Ca21 is a cytosolic species, measured in mMwhereas
the membrane-associated ﬂuxes such as J1 above are membrane density
ﬂuxes (mm2 s1). To convert to concentration ﬂuxes, it is convenient to




where Cc is a conversion factor from a number of particles to a cytosolic
concentration (mM), and Cp is a conversion factor from a number of particles
to a density on the cell’s plasma membrane (mm2). Together they give a
conversion factor that can be applied to the appropriate density ﬂuxes to give
the corresponding concentration ﬂuxes for cytosolic products, or vice versa.
A number of parameters were taken from the existing model by Lukas
(25), where appropriate. For the binding of Ca21 to PLCb-GaGTP (Ca
binding to Pg in reaction R11) only the dissociation constant (Kd,11) was
known. We have made the assumption that the forward rate constant for
reaction R11 is twice that of the similar reaction R8, due to the binding of
GaGTP. From this assumption the reverse rate constant for reaction R11 was
calculated.
The resting level of calcium in the cardiac myocyte was assumed to be
100 nM (28).
IP3 production and degradation
The species PLCb-Ca21 (Pc) and PLCb-Ca
21-GaGTP (Pcg) act as hy-
drolyzers, converting the substrate PIP2 to IP3, shown by reactions R14 and
R15 in Fig. 1, respectively. These catalytic reactions were modeled using
Michaelis-Menten kinetics according to the quasi-steady-state approxima-
tion, their equations therefore being of the form (J14 is shown as an example)





where the Km of the reaction is scaled by the conversion factor Cpc (see Eq. 1).
IP3 binds to IP3 receptors (IP3Rs) in the cell, which are also regulated by
calcium. It was assumed that the amounts of both IP3 and calcium bound are
negligible compared to their cytosolic concentrations, and therefore IP3Rs
do not effect the concentrations of those small species. IP3R activation
causes a minor cytosolic calcium spike from intracellular stores, followed by
a much larger sustained calcium inﬂux from outside the cell—this latter
phenomenon being known as capacitative calcium entry (29). In the protocol
of interest to this work, the extracellular entry does not occur, and the minor
initial spike is assumed to have little effect on the model calcium. The IP3Rs,
having no effect on the rest of the model, are therefore not included in this
formulation.
The hydrolysis of PIP2 also produces the membrane-bound diacylglyc-
erol species, but that is not considered in this model.
PIP2 is manufactured by the cell, and resupplied after use to the plasma
membrane via the breakdown of inositol phosphates (30). Since there is no
evidence that the level of PIP2 is rate-limiting (31), in the model PIP2 is
ﬁxed at its initial value.
A degradation reaction (R16) encompasses the dephosphorylation or
phosphorylation of IP3 to form inositol bisphosphate and inositol tetra-
phosphate, respectively. For the purposes of this model, the metabolic re-
cycling of IP3 from those products is not considered. The basal level of IP3
is therefore a balance between the basal production and the degradation rates
(reactions R14 and R16, respectively).
A published report (32) of a;30 nM peak in IP3 on stimulation by 100 nM
of ET-1, together with estimates of the peak-to-basal ratio of ;2:1 (33,34),
suggest that the basal concentration of IP3 in the mammalian myocyte is
;15 nM. This is the estimate used in this model. The kinetics of the basal
IP3 production reaction (via kf,14) were adjusted to provide this value. The
balancing degradation rate was known with more conﬁdence and kept as in
the literature (25).
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Morris analysis
The model was reﬁned to simulate the response to ET-1 stimulation (see
Results for a comparison of model behavior to experimental data). We then
sought to determine which parameters controlled the IP3 transient produced
by the system by undertaking a global sensitivity analysis following the
Morris method (35). TheMorris method is a screening algorithm: it ranks the
parameters of the model, by their average effect on a particular model sim-
ulation output, over a given range of parameter values. The global nature of
the analysis is applicable given the system’s high nonlinearity (36) and the
method has been shown to be as efﬁcient as commonly-used variance based
techniques in detecting factors of low sensitivity. It is also computationally
cheaper than such techniques (37) as the required number of model evalu-
ations varies linearly with the number of model factors.
The method yields a score for each parameter of the model estimating the
partial differential of an objective function with respect to that parameter.
We chose ﬁve objective functions to analyze the model by, to capture the
behavior of the resulting IP3 transient (these measures are illustrated graphi-
cally on a representative IP3 transient in Fig. 4):
Baseline Concentration. The basal concentration of IP3 established at
steady state before stimulation.
Time-to-Peak. Time in seconds from the stimulation time to the peak IP3
concentration.
PeakConcentration. Themaximumconcentration of IP3 during the transient.
Tau-to-Tail Ratio. The ratio of the time after the peak at which the tail of the
transient dips below 1/e of its peak amplitude, to the length of the tail
(from the peak to the return to baseline as in the next objective function).
Flatter transients have a higher Tau-to-Tail Ratio, closer to 1.0.
Time-to-Baseline. The time in seconds, since stimulation, for the return
to baseline concentration. Since returning transients can approach the
baseline asymptotically, we measured returning to baseline as oc-
curring when the amplitude of the transient had dropped below 10%
after the peak.
To determine the sensitivity of these measures to the model parameters,
we deﬁne for each parameter a range of values over which it can vary. These
may vary widely, whether by virtue of the very different quantities which
they represent, or simply by different physiological constraints. The amount
of variation of a parameter inside a particular range is normalized to a
fraction of that range, designated d. The parameter ranges deﬁned for our
analysis are listed in Table S1 in the Supplementary Material. Parameter
ranges were normalized and parameters allowed to take one of 16 equally
spaced values (Morris parameter p ¼ 16). For each parameter, changes in
each of the objective functions were measured for a d change over the range






This yields a sliding window of 53.3% of each parameter’s range. Param-
eters therefore begin each of a series of analysis trajectories at one of 16
values within their deﬁned range, and at each step of each trajectory, one
parameter is varied by 53.3% of that range, and the subsequent effect on
each the objective functions are measured.
Parameter change effects are divided by d, to give an estimate for the
parameter’s effect on each objective measure, over the parameter’s entire
deﬁned range. We ran two sets of 8000 trajectories as described by Morris
(35) for each parameter over the ﬁve objective functions (Morris parameter
r ¼ 8000), as we found this gave repeatable clustering and ordering (unless
parameters were very similar in signiﬁcance) results between the two sets.
For each test, the model was run to achieve steady state before agonist
stimulus was applied. Up to a further 130,000 s was simulated (;36 h) to
allow IP3 to peak and resume the baseline level again for all parameter sets
tested.
We then combined both sets of tests to give an overall population for each
parameter of 16,000 sensitivity measures, and used the Campolongo ex-
tension (38) of the method to calculate the mean absolute effect (m*) as
a direction-independent measure of sensitivity of the deﬁned normalized
ranges.
Tables S2–S6 in the Supplementary Material show the parameters ranked
by their effects thus calculated, for each of the ﬁve objective functions.
Angiotensin-II reﬁnement
We sought to determine whether the different IP3 transient produced by
Ang-2 (as opposed to ET-1) stimulation could be explained by receptor-
related parameters alone. A number of model parameters were therefore
adjusted to match known published kinetics for the Ang-2 receptors. It is
known that the rodent Ang-2 receptor has a larger dissociation constant than
the ET-1 receptor:;1.5 nM in rat and ferret, and that the receptor density is
much lower than that for ET-1, being approximately one-ﬁfth (see Table 25
in (28)). These literature-motivated parameter changes alone were not suf-
ﬁcient to explain the differences in the resulting IP3 transient. We therefore
investigated the most signiﬁcant remaining receptor-related parameters.
We used the results of the sensitivity analysis to identify the 10 most
signiﬁcant parameters with respect to the IP3 transient (see Table 1). Two of
these (kf,4 and kf,5) relate to kinetics associated with the receptors themselves,
and hence are likely to be different between ET-1 and Ang-2 receptors.
Experimental research by Abdellatif et al. (39) measured accumulation of
IP3 in cultured rat neonatal ventricular cardiac myocytes on stimulation of
100 mM Ang-2, using ion-exchange chromatography. During ﬁtting to this
data, we determined predicted new values for those signiﬁcant receptor
parameters using the Levenburg-Marquardt algorithm (implemented as the
‘‘levmar’’ nonlinear least-squares ﬁtting package obtained from http://www.
ics.forth.gr/;lourakis/levmar). Multiple runs were conducted in an attempt
to evade local minima, and a close ﬁt with the experimental data was
obtained. Varying additional parameters did not signiﬁcantly increase the
goodness-of-ﬁt.
RESULTS
IP3 transients in response to ET-1 stimulation
Model parameters were reﬁned to the mouse atrial myocyte
by ﬁtting the IP3 transient resulting from stimulation at var-
ious ET-1 strengths to experimental data from Jiang et al.
(40). Based on the available data, we performed the ﬁt based
on IP3 transient observations. To our knowledge data on the
TABLE 1 Ten most signiﬁcant model parameters
Rank Parameter Meaning
1 kf,5 Rate constant for the phosphorylation of active receptor.
2 Ls Full-strength ligand concentration during stimulation.
3 kf,4 Rate constant for the binding of ligand to precoupled
receptor.
4 kf,16 Rate constant for the degradation of IP3.
5 Rpc Ratio of plasma membrane surface area to cytosolic
volume.
6 Gd Area density of free inactive G-protein.
7 Kd,2 Dissociation constant for the precoupling of receptor.
8 kf,14 Rate constant for the nonstimulated IP3 production
reaction.
9 kf,8 Forward rate constant for the binding of calcium to
PLCb.
10 kr,8 Reverse rate constant for the binding of calcium to
PLCb.
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ET-1 stimulated responses of proteins upstream of IP3 do not
currently exist. Model parameters were adjusted until the out-
put from the model closely matched the experimental obser-
vations, to match the mouse atrial myocyte on stimulation by
the speciﬁc extracellular ligand ET-1.
To achieve the ﬁt, several parameters’ values had to be
changed from those derived from other sources. These changes
are presented in Table 4.
A comparison of an IP3 transient from the model with
experimentally determined IP3 time-course data from Jiang
et al. on 100 mM of ET-1 stimulation is shown in Fig. 2.
Simulation results were generated from the model deﬁned in
Table 3, with the parameters deﬁned in Table 4, and Ls ¼
0.100 mM, ts ¼ 30.0 s, to match the experimental protocol.
The numerical solver used was an implicit Runge-Kutta
method based on Radau quadrature, as described by Hairer
and Wanner (41). Absolute and relative error tolerances were
set at 109. As can be seen, the model behavior closely
matches experimental results.
A further comparison with IP3 transient data is shown in
Fig. 3. Jiang et al. measured the IP3 concentration in cells 30
min after stimulation with various concentrations of ligand.
To simulate this, the model’s ligand stimulation strength (Ls)
was varied at regular intervals from 13 104 mM to 1.0 mM,
and the concentration of IP3 measured 1800 s (30 min) after
ligand addition. Figs. 2 and 3 demonstrate that appropriate
IP3 transient behavior is produced by the model.
Key drivers of the IP3 transient
The most signiﬁcant parameters in terms of impact on the
IP3 transient are listed in Table 1. Parameters were sorted by
summing their proportional signiﬁcance for each objective
measure. A complete list of all model parameters and their
signiﬁcance scores can be found in Table S7 in the Supple-
mentary Material.
The single most important parameter is the receptor phos-
phorylation rate constant (kf,5). The quantity kf,5 governs the
reaction that terminates the signal by reducing the total avail-
able receptor density, and thus reducing the possibility of
sarcolemmal signal transduction in response to extracellular
hormonal stimulation. It is of critical importance for setting
the Time-to-Baseline, as without a phosphorylation step the
system would simply equilibrate based on the stimulation
concentration of ligand and the transient would be constant.
FIGURE 3 IP3 transient curve on ET-1 stimulation. The simulated IP3
transient closely matches experimental observations (40) on application of
100 nM ET-1. Simulations were performed with the equations as in Table 3
and the parameters and initial conditions as in Table 4. Additionally, ts¼ 30 s,
and Ls ¼ 0.100 mM.
FIGURE 4 IP3 dose-response curve on ET-1 stimulation. The model also
closely matches experimental observations (40) for the concentration of IP3,
after 30 min, on stimulation by various concentrations of ET-1. Simulations
were performed with the equations as in Table 3 and the parameters and
initial conditions as in Table 4. Additionally, ts ¼ 100 s, and the model was
run until (t ts)¼ 1800 s (30 min of stimulation) for each of Ls¼ 13 104,
53 104, 13 103, 53 103, 13 102, 53 102, 13 101, and 53 101mM.
FIGURE 2 IP3 transient-based objective measures. Graphical depiction
of the measures used to deﬁne the objective functions for the sensitivity
analysis. Tau is the time point at which the transient dips beneath 1/e 3
amplitude.
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Decreasing the phosphorylation rate via the kf,5 parameter
increases the tail as shown in Fig. 5. As can also be seen in
that ﬁgure, a higher kf,5 reduces the Time-to-Peak. While
lowering kf,5 increases the length of the transient’s tail it also
increases Tau. This is to be expected, however the increase in
Tau is proportionally less than the increase in the tail length.
Hence, over the range tested, the Tau-to-Tail Ratio reduces
as kf,5 increases. These three effects make the phosphorylation
rate of the receptors crucial to determining the transient’s be-
havior.
The following two parameters—the ligand strength (Ls)
and the rate constant for the binding of ligand to precoupled
receptor (kf,4)—have virtually identical effects across all ob-
jective function measures (see Table S7 in the Supplemen-
tary Material for quantitative details). We consider each in
turn.
It might be expected that the applied ligand concentration
(Ls) is signiﬁcant in determining the response. Ls is signif-
icant largely due to its effect on the Time-to-Peak, which is
demonstrated in Fig. 6. For stimulation with lower ligand
concentration, the transient ﬂattens and takes longer to ac-
hieve its maximum. This is due to the effect that ligand con-
centration has on the phosphorylation of available receptor.
With higher ligand concentration, more active receptor is
immediately available for phosphorylation, which turns off
the signal faster. For low ligand strength, less IP3 signal am-
plitude is achieved, but the receptor pool is not consumed as
quickly. This can be seen from a plot of the percentage of
phosphorylated receptor over time, as shown in Fig. 7 for the
highest and lowest ligand strengths in Fig. 6.
The forward rate constant for the binding of ligand to pre-
coupled receptor (kf,4) also heavily inﬂuences the formation
of activated receptors. This parameter has a large effect on
the Time-to-Peak. Examination of the changes in the mem-
brane density of various species reveals that the IP3 transient
closely follows the shape of the density curve on the active
receptors (the product of reaction R4) (see Fig. 8). The pa-
rameter kf,4’s effect on Time-to-Peak can thus be explained
by its inﬂuence on the production of active receptor, which in
turn leads to the peak for IP3.
FIGURE 5 Decreased kf,5 results in a higher peak and a longer time-to-
baseline from peak. Simulations were performed with the equations as in
Table 3 and the parameters and initial conditions as in Table 4. Additionally,
ts ¼ 100 s, Ls ¼ 0.100 mM, and kf,5 was varied as depicted in the legend.
FIGURE 6 Decreasing ligand strength strongly effects Time-to-Peak.
Lower ligand strength produces a slower rate of active receptor production,
thus the transient takes more time to achieve its maximum. Simulations were
performed with the equations as in Table 3 and the parameters and initial
conditions as in Table 4. Additionally, ts ¼ 100 s and Ls was varied as
depicted in the legend.
FIGURE 7 Higher ligand strength more readily increases phosphorylated
receptor density. Although the long-term gradients for phosphorylated
receptor density are similar for both high and low concentrations of ligand
strength, a higher strength yields a much larger initial gain. Simulations were
performed with the equations as in Table 3 and the parameters and initial
conditions as in Table 4. Additionally, ts ¼ 100 s and Ls was varied as
depicted in the legend.
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Both parameters also signiﬁcantly inﬂuence the Time-to-
Peak and the Tau-to-Tail Ratio. A higher peak due to high
active receptor formulation (as increased by kf,4, Ls and also
the parameter Gd) leads sooner to a more rapidly decreasing
transient, as receptors are more readily available to be phos-
phorylated faster. This gives a sharper peak earlier, with a
longer post-peak tail and therefore a lower Tau-to-Tail Ratio,
compared to a ﬂatter transient with a longer time to peak, a
shorter tail, and higher Tau-to-Tail Ratio when those param-
eters are lower. This is illustrated for kf,4 speciﬁcally in Fig.
9. The same effect occurs when Ls or Gd are decreased (not
shown).
The next most important parameter is the forward rate
constant (kf,16) for the degradation of IP3, which is the main
consumer of IP3 in this system. The ratio of sarcolemmal
surface area to cytosolic volume (Rpc) is also important as it
determines the cytosolic ﬂux in IP3 concentration resulting
from a given surface area on the plasma membrane (a smaller
cytosolic volume would yield a higher concentration change
for the same IP3-producing sarcolemmal surface area). Hence
this parameter has a direct effect on the concentration of
IP3 produced for a given stimulus. Both these parameters
mainly effect the IP3 Baseline Concentration and the Peak
Concentration—one parameter affecting via IP3 degradation
and the other affecting production, respectively.
The top ﬁve parameters together represent the most impor-
tant determinants for each of the ﬁve objective functions—kf,5
for Time-to-Baseline, Ls and kf,4 both equally for each of Time-
to-Peak and Tau-to-Tail Ratio, and both kf,16 and Rpc for each
of Baseline and Peak Concentration.
The value Gd represents the densities of a species required
to form that mobile messenger—the amount of free GaGDP.
Gd’s effects on Tau-to-Tail Ratio and Time-to-Peak is similar
to the effect of kf,4 or Ls, as has already been discussed, being
a multiplicative factor in the forward rates of both reactions
R2 and R3, which form active receptors.
Kd,2 has similar but less pronounced effects toGd, which is
due to it being a determinant of the rate of precoupled re-
ceptor formation, and therefore inﬂuences the rate of produc-
tion of active receptors.
The basal IP3 production forward rate constant (kf,14) is
also important, largely for its effect on the Baseline Concen-
tration. This is expected since the basal IP3 concentration is a
balance of reaction R14 and the degradation rate as previ-
ously discussed.
The next two parameters of importance are the forward
and reverse rate constants for the binding of calcium to PLCb.
The PLCb-Ca21 so produced is the only enzyme capable of
producing IP3 in this system without ligand stimulation. Hence
their effect on Baseline and Peak Concentrations, while less
than that of other parameters such as kf,16 and Rpc, is notable.
Together these are the most signiﬁcant control parameters
of the IP3 model. They are also, therefore, the key param-
eters to be determined experimentally for a species of inter-
est, as they have the strongest effect on the time course of the
IP3 transient after stimulation of the Gq protein-coupled re-
ceptors.
Angiotensin-II stimulation
The literature-derived and reﬁnement-ﬁtted parameter changes
required to adjust the model (as discussed in Methods) for
Ang-2 cell stimulation are shown in Table 2. A graph of the
experimental observations together with the ﬁtted IP3 tran-
sient is shown in Fig. 10.
FIGURE 8 The IP3 transient follows the active receptor transient. Simu-
lations were performed with the equations as in Table 3 and the parameters
and initial conditions as in Table 4. Additionally, ts¼ 100 s and Ls¼ 0.100mM.
FIGURE 9 Higher kf,4 reduces the Tau-to-Tail Ratio. Increased kf,4 gives
sharper peaks, but longer tails from the peak, and a lower Tau-to-Tail Ratio
compared to ﬂatter transients with a higher ratio when kf,4 is decreased.
Simulations were performed with the equations as in Table 3 and the
parameters and initial conditions as in Table 4. Additionally, ts¼ 100 s, Ls¼
0.100 mM, and kf,4 was varied as depicted in the legend.
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Three parameters were adjusted during the reﬁnement. An
increase in kf,5 is needed to reduce the length of the transient
to the shorter Ang-2 response. A minor adjustment to kf,4 (less
than an order of magnitude) was also made. A third param-
eter was also modiﬁed—for forward rate constant for the dis-
sociation of the messenger GaGTP from active receptors
(kf,6). This modiﬁcation was necessary due to the increased
kf,5, which results not only in a shorter tail, but a lower peak.
By increasing kf,6, more signal can be transferred to the PLCb
module via the messenger GaGTP, raising the IP3 transient
peak without greatly increasing the tail. This combination of
parameter changes, in concert with those derived from the
literature, was sufﬁcient to explain the experimental data.
Thus, once we allow for different receptor densities and
known kinetic differences, the difference between the ET-1-
and Ang-2-induced IP3 transients can be explained solely in
terms of additional receptor kinetic changes in the phospho-
rylation rate (via rate constant kf,5), the binding of extracel-
lular ligand to the precoupled receptor (kf,4) and the release
of active G-protein (kf,6).
DISCUSSION
We have presented the ﬁrst model of the IP3 production
system in the atrial cardiac myocyte. We used this model to
1), assess the key drivers of the IP3 transient system; and 2),
hypothesize the kinetic mechanism that allows two different
receptors to provoke different behaviors in the same down-
stream pathway.
The IP3 system
The sensitivity analysis showed that several parameters that
we expected to be important were in fact signiﬁcant, increasing
our conﬁdence in the model. It also rated some parameters
unexpectedly high—indications which have led to further
insights on the functioning of the IP3 production system.
That the phosphorylation rate of the receptor (via kf,5) is of
high importance is expected. There are two other switch-off
points for the stimulated IP3 transient—the GaGTP self-
hydrolysis to GaGDP when mobile (via kf,7), or when bound
to PLCb-Ca21 (via kf,12 and kf,13). The fact that the phos-
phorylation rate of the receptor is more important than these
highlights the importance of the interface of the cell to the
surroundings above the internal mechanisms, at least in this
system.
It is also intuitive that the ligand strength (Ls) is important.
What is perhaps less obvious but shown by the sensitivity
analysis is that this effect seems to be due largely to the li-
gand’s effect on precoupled receptor density as opposed to
its effect on noncoupled receptor density. The impact of Ls is
identical to that of the forward rate constant for the binding
of that ligand to precoupled receptor. This is explainable by
FIGURE 10 Simulated ﬁt to the observations of Abdellatif et al. (39). The
simulated transient matches the observations (39) for stimulation with 100
nM of Ang-2. Simulations were performed with the equations as in Table 3
and the parameters and initial conditions as in Table 4, and the Ang-2 values
listed in Table 2. Additionally, Ls ¼ 100 mM and ts ¼ 100 s.
TABLE 2 Parameters altered during reﬁnement to angiotensin experimental data
Symbol Meaning ET-1 value Ang-2 value Source
Kd,1 Dissociation constant for the binding of ligand to the
receptor with no attached G-protein.
3.00 3 105 mM 1.50 3 103 mM* Bers (28)
Kd,2 Dissociation constant for the binding of unbound
receptor to G-protein.
2.75 3 104 mm2 2.74 3 104 mm2y
Kd,4 Dissociation constant for the binding of ligand to the
receptor with attached G-protein.
3.00 3 105 mM 1.50 3 103 mM* Bers (28)
kf,4 Forward rate for the binding of ligand to precoupled
receptor.
3.00 3 101 mM1 s1 6.02 3 101 mM1 s1 (ﬁtted value)
kf,5 Receptor phosphorylation rate. 4.00 3 10
4 s1 6.22 3 102 s1 (ﬁtted value)
kf,6 G-protein dissociation rate from the activated receptor. 1 s
1 22.2 s1 (ﬁtted value)
R Density of noncoupled receptors. 13.9 mm2 2.93 mm2 Bers (28)
Rg Density of receptors coupled with G-proteins. 5.06 mm
2 1.07 mm2 Bers (28)
*In keeping with the ET-1 model, Kd,1 and Kd,4 retain their equality to one another.
yDue to rounding for the values of R and Rg, the kinetic constant Kd,2 also had to be adjusted as the precise ﬁgure was closer to 27,400 than 27,500 mm
2, to
achieve the same steady-state levels of R and Rg.
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both being multiplicative factors in that reaction (R4). It is
such reaction that is important for the formation of active
receptors (Rlg) on stimulation by ligand. The noncoupled
reaction (R1) is less important on the stimulation of ligand as
a further reaction must then be carried out (reaction R3) for
theGaGDP to bind to the ligand-receptor complex before the
receptor is active. In the precoupled state, the receptor be-
comes active much more readily and determines the respon-
siveness of the system far more signiﬁcantly.
It seems likely that the effect on precoupled receptor
density is also why the amount of GaGDP and the dissocia-
tion constant for receptor precoupling (Kd,2) are signiﬁcant at
numbers six and seven in the top 10—which may have at
ﬁrst seemed puzzling. GaGDP is a reactant for the formation
of precoupled receptors (Rg), which in turn are reactants for
that important reaction R4.
That the degradation rate of IP3 (via kf,16) and geometric
ratio of membrane area-to-cytosolic volume (Rpc) are impor-
tant is also expected when their role in the degradation and
production of IP3, respectively, is considered, as was noted
above. That the parameters (kf,8 and kr,8) related to the for-
mation of the basal PIP2-hydrolyser (Pc) and the subsequent
hydrolysis reaction (kf,14) are important is not surprising, given
that the Baseline Concentration was one of the objective
functions. The availability of Pc inﬂuences the resulting stim-
ulated transient also, as mass of PLCb is conserved when
forming the stimulated hydrolyser Pcg, and kf,14 inﬂuences
the difference between Pc activity and Pcg activity, having
implications for the tail of the IP3 transient. Hence overall
these are among the more signiﬁcant parameters of the system.
Of the top seven parameters, ﬁve relate to the receptor
kinetics. This highlights again the importance of the cell/
environment interface in this system and indicates how a
change in receptor density and kinetics from ET-1 to Ang-2
can alter the resulting IP3 transient to the extent observed
experimentally.
Drivers of the angiotensin-II IP3 transient
Taken together, only parameters relating to the receptor ki-
netics and density have been altered to yield the ﬁts to ex-
perimental data. Hence the model is consistent with the idea
that a shorter IP3 transient from Ang-2 compared to ET-1
can be produced simply by a change in the type and number
of receptors without the need for any other mechanisms.
The change in phosphorylation rate of active receptor (via
constant kf,5) is consistent with the observation that the re-
ceptor phosphorylation rates differ even between subtypes of
the same receptor (42). As discussed above, this phospho-
rylation rate is the most important factor in determining the
time for the transient to reach the baseline level again after
stimulation. Therefore in determining the possible differ-
ences in receptor kinetics between ET-1 and Ang-2 binding
receptors, an increase in the phosphorylation rate (to reduce
the transient’s time length) for Ang-2 receptors seems likely.
The increase required in the dissociation rate of active
G-protein subunits from the receptor (kf,6) suggests that, in
cardiomyocytes, along with an increased phosphorylation
rate (compared with endothelin receptors), the AT-1 receptor
may also have an increased rate of GaGTP dissociation from
the activated receptor compared to that of the ET-1A recep-
tor. This prediction, and the increase in the rate of binding of
ligand to precoupled receptor (kf,4), could be investigated ex-
perimentally.
We also reﬁned the model to a second Ang-2 dataset from
rat neonatal ventricular myocytes, that of Sadoshima and Izumo
(43), which measured IP3 transients at two different con-
centrations of Ang-2. The experimental observations were too
coarsely grained for our purposes to be conﬁdent about the
TABLE 3 IP3 model equations
Cc ¼ 1Vc 3 6:0223 102
Cp ¼ 1Vc 3Rpc
Cpc ¼ CcCp
L ¼ Ls
1:01 e80:03 ððttsÞ0:05Þð Þ
if ðt, ðts1 0:15ÞÞðt$ tsÞ; Ls; if t$ ðts1 0:15Þ;0 otherwise.
kr,1 ¼ kf,1 3 Kd,1
J1 ¼ kf,1 3 R 3 L  kr,1 3 Rl
kr,2 ¼ kf,2 3 Kd,2
J2 ¼ ðkf;23R3Gd  kr;23RgÞ
dR
dt ¼ ðJ11 J2Þ
J3 ¼ kf,3 3 Rl 3 Gd  kr,3 3 Rlg
dRl
dt ¼ J1  J31 J6
kr,4 ¼ kf,4 3 Kd,4
J4 ¼ kf,4 3 L 3 Rg  kr,4 3 Rlg
dRg
dt ¼ J2  J4
dGd
dt ¼ J121 J71 J13  ðJ21 J3Þ
J5 ¼ kf,5 3 Rlg
dRlgp
dt ¼ J5
J6 ¼ kf,6 3 Rlg
dRlg
dt ¼ J31 J4  ðJ51 J6Þ
J7 ¼ kf,7 3 Gt
dGt
dt ¼ J6  J7  J9  J10
J9 ¼ kf, 9 3 P 3 Gt  kr,9 3 Pg
J8 ¼ kf, 8 3 P 3 Ca  kr,8 3 Pc
J10 ¼ kf,10 3 Pc 3 Gt  kr,10 3 Pcg
kr,11 ¼ kf,11 3 Kd,11
J11 ¼ kf,11 3 Pg 3 Ca  kr,11 3 Pcg
J12 ¼ kf,12 3 Pcg
J13 ¼ kf,13 3 Pg











dt ¼ J13  ðJ91 J8Þ
dPg
dt ¼ J9  ðJ111 J13Þ
dPc
dt ¼ J81 J12  J10
dPcg
dt ¼ J101 J11  J12
J16 ¼ kf,16 3 IP3
dIP3
dt ¼ ðJ141 J15Þ3Cpc  J16
dCa
dt ¼ Cpc3 13 ðJ81 J11Þ
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peak of the transient, but best ﬁts were achieved with similar
values for kf,5 and kf,6 (0.0421 s
1 compared with 0.0622 s1
and 14.9 s1 compared with 22.2 s1, respectively), increas-
ing our conﬁdence in the roles of the receptor phosphoryl-
ation and active G-protein dissociation rates.
The importance of the receptor phosphorylation rate, as
evidenced both by the sensitivity analysis and its role in the
ﬁtting of the Ang-2 dataset, highlights the value of experi-
mental measurement of this parameter for receptors of in-
terest. Often experiments focus on determining the binding
TABLE 4 Model parameters and initial conditions
Symbol parameters Description Units Value Source
kf,1 R1 forward rate constant mM
1 s1 3.00 3 104 (ﬁtted value)*
Kd,1 R1 dissociation constant mM 3.00 3 10
5 Bers (28)
kf,2 R2 forward rate constant mm
2 s1 2.75 3 104 Lukas (25)
Kd,2 R2 dissociation constant mm
2 27,500 Lukas (25)
kf,3 R3 forward rate constant mm
2 s1 1.00 Lukas (25)
kr,3 R3 reverse rate constant s
1 1.00 3 103 Lukas (25)
kf,4 R4 forward rate constant mM
1 s1 3.00 3 101 (ﬁtted value)y
Kd,4 R4 dissociation constant mM 3.00 3 10
5 Bers (28)
kf,5 R5 forward rate constant s
1 4.00 3 104 (ﬁtted value)z
kf,6 R6 forward rate constant s
1 1.00 Lukas (25)
kf,7 R7 forward rate constant s
1 1.50 3 101 Lukas (25)
kf,8 R8 forward rate constant mM
1 s1 1.67 3 102 Lukas (25)
kr,8 R8 reverse rate constant s
1 1.67 3 102 Lukas (25)
kf,9 R9 forward rate constant mm
2 s1 4.20 3 103 Lukas (25)
kr,9 R9 reverse rate constant s
1 1.00 Lukas (25)
kf,10 R10 forward rate constant mm
2 s1 4.20 3 102 Lukas (25)
kr,10 R10 reverse rate constant s
1 1.00 Lukas (25)
kf,11 R11 forward rate constant mM
1 s1 3.34 3 102 See discussion under PLCb Cycling
Kd,11 R11 dissociation rate constant mM 1.00 3 10
1 Lukas (25)
kf,12 R12 forward rate constant s
1 6.00 Lukas (25)
kf,13 R13 forward rate constant s
1 6.00 See discussion under PLCb Cycling
kf,14 R14 forward rate constant s
1 4.44 3 101 See discussion under IP3 Production and
Degradation
Km,14 R14 Km value mM 19.8 Bhalla and Iyengar (49)
kf,15 R15 forward rate constant s
1 3.80 (ﬁtted value)§
Km,15 R15 Km value mM 5.00 Bhalla and Iyengar (49)
kf,16 R16 forward rate constant s
1 1.25 DOQCS1 database (50)
Ls Ligand stimulation concentration mM varies User-deﬁned
PIP2 PIP2 density mm2 4000 Xu et al. (51)
ts Time of stimulation s varies User-deﬁned
Vc Cytosolic volume mm
3 2549.3 Leri et al. (52), Bers (28)
Initial conditions
Ca Cytosolic Ca21 concentration mM 1.00 3 101 Bers (28) (steady state)
Gd GaGDP density mm
2 10,000 Lukas (25) (steady state)
Gt GaGTP density mm
2 0.00 (unstimulated)
IP3 IP3 concentration mM 0.015 See discussion under IP3 Production and
Degradation
L Ligand concentration (extracellular) mM 0.00 (unstimulated)
P PLCb density mm2 90.9 Lukas (25) (steady state)
Pc PLCb-Ca
21 density mm2 9.09 Lukas (25) (steady state)





R Noncoupled receptor density mm2 13.9 Kobayashi (53) (steady state)
Rg Precoupled receptor density mm
2 5.06 Kobayashi (53) (steady state)
Rl Ligand-bound receptor density mm
2 0.00 (unstimulated)
Rlg Active receptor density mm
2 0.00 (unstimulated)
Rlgp Phosphorylated receptor density mm
2 0.00 (unstimulated)
Rpc Plasma membrane/cytosolic volume ratio mm
1 4.61 Bers (28)
All parameters are as at steady state. Fitted values are as a result of reﬁnement to ET-1 data. See footnotes below.
*Altered from 1.68 3 102 (25).
yAltered from 16.8 (25).
zAltered from 3.00 3 102 (25).
§Altered from 48.0 (49).
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constants to certain ligands. As we have shown, for signal
transduction the resulting intracellular signal is heavily in-
ﬂuenced by the temporal dynamics of receptor activation,
which is a balance between the binding of the ligand and the
molecular events that switch-off active receptors. For the
purposes of signal transduction, the determination of kinetic
parameters pertaining to signal termination events may be
even more important than the traditional focus on binding
rates (kf,5 was overall the most important parameter).
Future directions
We have concluded that the rate of receptor deactivation is
crucial for determining the behavior of the stimulated tran-
sient. In vivo the signal is stopped by several receptor desen-
sitization mechanisms, including phosphorylation, binding
of an inhibitor protein to the receptor, and receptor inter-
nalization. The details of exactly which process leads to de-
sensitization differ depending on cell and receptor type. For
example, phosphorylation may not play a role in the inter-
nalization of b-2 adrenergic receptors, but may play a role in
muscarinic acetylcholine receptors (44). Also, with respect
to the path the receptor takes once internalized, even differ-
ent isoforms of the same receptor can take different routes.
For example, in Chinese hamster ovary cells, endothelin iso-
form A (ET-A) receptors were found to be routed to a re-
cycling compartment while endothelin isoform B (ET-B)
receptors appeared to be destroyed in internal lysosomes (45).
It is also possible that recycling can occur via multiple path-
ways with different timescales, as it appears to do for the
human V2 vasopressin receptor (46). The full desensitization-
sensitization cycle of ET-A receptors in the cardiac myocyte
is not completely understood. Therefore, in this work, re-
ceptor desensitization is modeled simply as a phosphoryl-
ation step. Experimentally, ET-A phosphorylation appears to
be correlated with desensitization (27). There is, however,
some evidence (42) that ET-A desensitization occurs via
internalization rather than phosphorylation, hence what in
the model is called phosphorylation may in reality be
internalization.
While for the purposes of model functionality both ab-
stractions are largely identical (being essentially a removal of
receptors from availability), it may be useful to extend the
model with details of this internalization and recycling, once
known. This would allow themodel to respond tomultiple stim-
uli, as receptors could then get replenished post-phosphorylation.
The question of how the longer timescale process of receptor
recycling inﬂuences hypertrophic signaling could then also
be explored.
This model assumes a resting level of calcium, similar to
that employed in the experiments of Jiang et al. (40). In a
beating heart, the calcium levels oscillate. From the sensi-
tivity analysis the parameter Ca corresponding to cytosolic
calcium concentration ranked 11th overall, due to its effects
on Baseline and Peak Concentration of the IP3 transient, and
hence is likely to have a minor but measurable effect. It will
therefore be interesting to explore the behavior of the model
during a calcium oscillation and eventually couple to models
of cell electrophysiology and excitation-contraction coupling
(47,48). Comparing model results to experimental observa-
tions of IP3 transients in beating cells would extend our un-
derstanding of calcium handling in this system as it impacts
on signal transduction.
The signal transduction pathway is complex and there are
many kinetic parameters that could be measured. We present
the top 10 parameters as those most likely to inﬂuence the
IP3 transient formed in response to extracellular ligand. To
conﬁrm our understanding of this pathway in the cardiac
myocyte it would be helpful to make experimental observa-
tions of these parameters and compare them to modeled val-
ues, thus reﬁning the model as such data becomes available.
A further source of reﬁnement would be transient data post
ET-1 stimulation in the mouse atrial myocyte for proteins
upstream of IP3; for example, free GaGTP or calcium-bound
PLCb. To our knowledge no such data exists, but such data
could be used to constrain the model and reﬁne its accuracy
for behavior upstream of the IP3 transient.
The model predictions for the Ang-2 reﬁnement are per-
haps limited by the fact that we used data from rat ventricular
myocyte, whereas the ET-1 stimulated model was developed
in the mouse atrial myocyte. It is assumed that the Ang-2
induced IP3 transient would be sufﬁciently similar between
the two cell types. To improve the validity of the reﬁnement,
it would be advantageous to conduct measurements of the
Ang-2 induced IP3 transient in the mouse atrial myocyte and
check that a similar reﬁnement can be performed.
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